Biopharma's New Drug for COPD Likely to be Approved Research Report

Retrieved on: 2024-04-22 19:24:45

Tags for this article:

Investment banking

Pharmaceutical industry in China

Securities research

Chronic obstructive pulmonary disease

Financial analyst

H.C. Wainwright & Co. LLC

H.C. Wainwright & Co.

Ram Selvaraju

Verona Pharma plc

Click the tags to see associated articles and topics

Biopharma's New Drug for COPD Likely to be Approved Research Report. View article details on hiswai:

Excerpt

Ram Selvaraju in a March 4 research note. Also, the biopharma's 2023 financial results are in. "Verona appears substantively risk mitigated, and we ...

Article found on: www.streetwisereports.com

View Original Article